LG Electronics' plan to increase outsourcing of its low to mid-end smartphones to cut costs and compete with Chinese rivals would not work without proper marketing, warns Tom Kang, an analyst at research firm Counterpoint.
Kang noted that without marketing ability, LG will not win against Chinese firms who are good at it.
LG reorganized its mobile phone division to come up with a new unit dubbed original design manufacture (ODM), which refers to the outsourcing of design and manufacture of smartphones, with the brand putting its label on the product.
It has also abolished some research and production positions while reshuffling others as part of an effort to focus its in-house R&D and production on premium smartphones, with low and mid-end ones to be produced by ODM.
LG’s mobile communications business suffered operating losses for 22 consecutive quarters.
Ranking third in the global smartphone market in the first quarter of 2013 by Strategy Analytics, LG did not even make it among the top seven in the third quarter this year. Chinese smartphone makers Huawei, Xiaomi, Oppo, and Vivo topped the list, according to Counterpoint.


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



